CARBOHYDRATE METABOLISM ABNORMALITIES IN PATIENTS WITH CANCER OF MAJOR DUODENAL PAPILLA BEFORE AND AFTER PANCREATICODUODENAL RESECTIONS

Cover Page

Abstract


56 patients with cancer of major duodenal papilla were examined before and after pylorus-saving pancreaticoduodenal resection. Carbohydrate metabolism was estimated before and after the operation, impact of the operation on diabetes mellitus progression was detected. If there were no carbohydrate metabolism abnormalities in 75% before the operation, then there were 55% of such patients after the operation. After the pylorus-saving pancreaticoduodenal resection the impaired glucose tolerance was detected in 4 (7%) of patients whose carbohydrate metabolism had corresponded to norms before the operation. 7 (13%) Of 17 (31%) patients had diabetes mellitus of mild severity after the pylorus-saving pancreaticoduodenal resection, the rest 10 (18%) had diabetes mellitus of moderate severity. In 7 (13%) patients after the pylorus-saving pancreaticoduodenal resection the diabetes mellitus of moderate severity was detected for the first time, at that in 4 patients diabetes mellitus of mild severity was detected, and in 3 patients — diabetes mellitus of moderate severity (everyone received insulin therapy in the long-term postoperative period) was detected. Checking protocol of the patients’ carbohydrate metabolism in the perioperative period was described in detail. The possibility of prognostication of carbohydrate metabolism abnormalities in the long-term postoperative period by indications of carbohydrate metabolism before the operation and in early postoperative period was studied. Middle blood glucose level in early postoperative period is an informative indication for prognostication of carbohydrate metabolism state in the long-term postoperative period. An algorithm of patients’ examination with cancer of major duodenal papilla before the operation and after it was offered; also checking protocol of carbohydrate metabolism indices and correction of the detected abnormalities in the early postoperative period were offered.

 


A. N. Lebedeva

Federal State Institution «A.V. Vishnevsky Institute of Surgery», Ministry of Public Health and Social Development

Author for correspondence.
Email: lebedeva@ixv.comcor.ru

Russian Federation кандидат медицинских наук, врач-эндокринолог ФГБУ «Институт Хирургии им. А.В. Вишневского» Минздравсоцразвития России Адрес: Москва, ул. Б. Серпуховская, д. 27 Тел.: (499) 236-61-44

V. S. Demidova

Federal State Institution «A.V. Vishnevsky Institute of Surgery», Ministry of Public Health and Social Development

Email: demidova@ixv.comcor.ru

Russian Federation доктор биологических наук, заведующая клинико-диагностическим отделом ФГБУ «Институт хирургии им. А.В. Вишневского» Минздравсоцразвития России Адрес: Москва, ул. Б. Серпуховская, д. 27 Тел.: (499) 236-45-20

A. G. Kriger

Federal State Institution «A.V. Vishnevsky Institute of Surgery», Ministry of Public Health and Social Development

Email: vishnevskogo@ixv.comcor.ru

Russian Federation доктор медицинских наук, профессор, заведующий I абдоминальным отделением ФГБУ «Институт хирургии им. А.В. Вишневского» Минздравсоцразвития России Адрес: Москва, ул. Б. Серпуховская, д. 27 Тел.: (499) 236-45-20

  1. Malyarchuk V.I., Klimov A.E., Pautkin Yu.F. Biliopankreatoduodenal’nyj rak. — M.: Izdatel’stvo RUDN, 2009, 444 s.
  2. WHO 1999 — Definition, Diagnosis and Classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of diabetes mellitus.
  3. Callephy E.E., Rodriguez С. et. al. Diabetes mellitus and pancreatic cancer mortality in prospective cohort of united States adults. Cancer Causes and control. 1998; 9: 403–410.
  4. Di Magno E.P. Pancreatic cancer: clinical presentation, pitfalls and early clues. Ann Oncol. 1999; 10(4): 140–142.
  5. Perment J., Ihse I., Jorfeldt L. et. al. Pancreatic cancer is associated with impaired glucose metabolism. Eur. J. Chir. 1993; 159: 101–7.
  6. Noy A., Bilezikian J.P. Clinical review 63, diabetes and pancreatic cancer: clues to early diagnosis of pancreatic malignancy. J. Clin. Endocrin. Metab. 1994; 79: 1223–1231.
  7. Slezak L.A., Andersen D.K. Pancreatic resection: effect of glucose metabolism. World J. Surg. 2001; 25(4): 452–460.
  8. Miyata M., Tiakao T., Uozumi T. et. al. Insulin secretion after pancreatduodenectomy. Ann. Surg. 1974; 179: 494–497.
  9. Krechler T., Novotny J., Zeman M.. et. al. Pancreatic carcinoma and diabetes mellitus. Cas. Lek. Cesk. 2004; 143 (2): 97–100.
  10. Rusakov V.I., Sulimov E.P., Sozykin A.F. Hirurgicheskoe lechenie raka golovki podzheludochnoj zhelezy, faterova soska i dvenadcatiperstnoj kishki. Hirurgiya. 1986; 7: 86-90.
  11. Dedov I.I., Shestakova M.V.Algoritmy specializirovannoj medicinskoj pomoschi bol’nym saharnym diabetom. Moscow: 2009, 103 s.

Views

Abstract - 16

PDF (Russian) - 6

Cited-By


PlumX



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.